Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer

MLA

Stuti Shroff, et al. “Concurrent Nab-Paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer.” American Journal of Clinical Oncology, vol. 44, no. 9, July 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....65e8550b9eef23f792c2aefeb1fcf0f3&authtype=sso&custid=ns315887.

APA

Stuti Shroff, Major K. Lee, James M. Metz, Edgar Ben-Josef, Ursina R. Teitelbaum, Kim A. Reiss, William Tristram Arscott, Kevin T. Nead, Mark H. O’Hara, John N. Lukens, Andrzej P. Wojcieszynski, Jacob E. Shabason, Jeffrey A. Drebin, Sriram Venigalla, Adham S. Bear, John P. Plastaras, & Arturo Loaiza-Bonilla. (2021). Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer. American Journal of Clinical Oncology, 44(9).

Chicago

Stuti Shroff, Major K. Lee, James M. Metz, Edgar Ben-Josef, Ursina R. Teitelbaum, Kim A. Reiss, William Tristram Arscott, et al. 2021. “Concurrent Nab-Paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer.” American Journal of Clinical Oncology 44 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....65e8550b9eef23f792c2aefeb1fcf0f3&authtype=sso&custid=ns315887.